EFNS-ENS Guidelines on the diagnosis and management of disorders associated with dementia.
about
Microvascular pathology and morphometrics of sporadic and hereditary small vessel diseases of the brainDementia and neuroimaging.Demography, diagnostics, and medication in dementia with Lewy bodies and Parkinson's disease with dementia: data from the Swedish Dementia Quality Registry (SveDem).Gains in cognition through combined cognitive and physical training: the role of training dosage and severity of neurocognitive disorder.Current status and future role of brain PET/MRI in clinical and research settings.Structural Magnetic Resonance Imaging Markers of Alzheimer's Disease and Its Retranslation to Rodent Models.Brain imaging in dementia.Occupational exposure to mineral turpentine and heavy fuels: a possible risk factor for Alzheimer's disease.Is ioflupane I123 injection diagnostically effective in patients with movement disorders and dementia? Pooled analysis of four clinical trials.A retrospective study of the clinical and electrophysiological characteristics of 32 patients with orthostatic myoclonus.The Extension of the German CERAD Neuropsychological Assessment Battery with Tests Assessing Subcortical, Executive and Frontal Functions Improves Accuracy in Dementia Diagnosis.Green tea consumption affects cognitive dysfunction in the elderly: a pilot study.SveDem, the Swedish Dementia Registry - a tool for improving the quality of diagnostics, treatment and care of dementia patients in clinical practice.Medial temporal lobe atrophy is underreported and may have important clinical correlates in medical inpatients.Guidelines for dementia or Parkinson's disease with depression or anxiety: a systematic review.Pathology and pathogenesis of vascular cognitive impairment-a critical updateEffects of green tea consumption on cognitive dysfunction in an elderly population: a randomized placebo-controlled studyDoes MRI Increase the Diagnostic Confidence of Physicians in an Outpatient Memory ClinicIdentification of promethazine as an amyloid-binding molecule using a fluorescence high-throughput assay and MALDI imaging mass spectrometry.Non-Alzheimer's disease-related memory impairment and dementia.Early-onset dementias: diagnostic and etiological considerations.Amyloid-beta immunotherapy: the hope for Alzheimer disease?Inadequate diagnostic evaluation in young patients registered with a diagnosis of dementia: a nationwide register-based study.Neuropsychiatry of corticobasal degeneration and progressive supranuclear palsy.The contribution of language to the right-hemisphere conceptual representations: a selective survey.Cognitive impairment in chronic kidney disease: clinical findings, risk factors and consequences for patient care.Advances in imaging-genetic relationships for Alzheimer's disease: clinical implications.Preferences regarding disclosure of a diagnosis of dementia: a systematic review.Challenges of multimorbidity of the aging brain: a critical update.Clinical workout for the early detection of cognitive decline and dementia.Pathogenesis and treatment of vascular cognitive impairment.Atypical association of semantic dementia, corticobasal syndrome, and 4R tauopathy.Updated meta-analysis of the role of APOE ε2/ε3/ε4 alleles in frontotemporal lobar degeneration.Multidimensional assessment of challenging behaviors in advanced stages of dementia in nursing homes-The insideDEM framework.Kynurenines and other novel therapeutic strategies in the treatment of dementia.Predictive genetic testing for amyotrophic lateral sclerosis and frontotemporal dementia: genetic counselling considerations.The Clinical Use of Cerebrospinal Fluid Biomarkers for Alzheimer's Disease Diagnosis: The Italian Selfie.Cerebrospinal fluid tau and amyloid-β1-42 in patients with dementia.[Diagnostic imaging in dementia: use of imaging modalities in Dutch memory clinics].First translational 'Think Tank' on cerebrovascular disease, cognitive impairment and dementia.
P2860
Q26824027-E22C48F3-875C-4533-A900-2264D6A7B447Q30581757-3DA1DCC1-A3A1-45EE-BEFE-0908AE7FA01EQ30654813-FC6981CF-09C0-400F-814B-7E6D72B30705Q30660336-1328D7AC-A6E9-4D24-8442-2F6B2DE652FFQ30883711-5FD63E8F-06EA-489D-8B67-822F1A0DA5AFQ30996675-6BB241B8-3BF8-4679-BE8E-BDCAF7D543E0Q31051218-51D2B8EF-219D-448B-ABD2-70E159473DD5Q33860532-7D01B1E2-BE39-41AE-8537-CC5EE4634F85Q33879821-BC40CDA7-E4E9-4DED-AE48-D733C4B9ECB1Q34016992-CA429D3F-CB44-4E7B-871D-79D752A4A7F6Q34250070-4FF5AC65-05D9-4B6E-950C-6500445A6F66Q34411608-25287DA7-7159-44BD-BF89-6F75EC5A8969Q35103331-860CCC02-E553-4EEE-B069-81B4DA121CBBQ35664424-717FDA66-55C3-4CDB-9BAC-B6515874EB24Q36204169-69017DE3-BAB6-4F70-8366-F50C618FF281Q36754568-2FD34556-1C4A-4AC1-9181-8179E8BD4ED8Q36866895-72687C4B-AFDB-49FA-8610-81DFF4844CCCQ37122838-B83C1714-9AAA-459D-B1E2-2CE6208DF688Q37185672-4C1F1E8F-EB3D-46D2-B2D9-FC986D68DC30Q37503811-30E57ED2-A265-4D98-B4BA-B592913C8829Q37606162-7C8F07B2-92B9-4AB8-86CB-901EB3020E4EQ37679265-60897749-91D8-4C17-9D5A-95D8AB61AF37Q37687516-D9BEF7F3-EB53-41A8-911D-8FC2724C3AE1Q38101088-8F3FF8C8-58B3-4297-84A1-59B045D91E42Q38107227-C4B35C05-BE3D-4F9B-A8D6-8FEC6EE2C87FQ38180990-EC156AD6-601B-4F3C-A667-A142055DFE49Q38196862-D909D0D9-E05A-4199-9A99-3C75104C28BFQ38220598-C1027719-AED4-44F9-95D1-D3CDD2978F5DQ38236878-746B9B1C-AE75-42EC-A32D-70F2FB9AABFEQ38255755-B16DFEAA-650F-4CDC-B671-0FD0BA0E650CQ38297016-0B6B92E1-CDE9-4D6F-91E8-82E908244CE9Q38442456-65AB27E4-9FA8-45AC-B499-DACFD558547AQ38795201-B21D94B8-5D26-4952-AD54-F85DA47F43EAQ38809852-2194EEF7-1926-4F29-AF38-C653243F397EQ39315645-A905AB51-C7FE-4D9E-B2AB-EF467FBD65FBQ39354046-95F325DF-0EE9-4C2A-8127-823644CBA094Q40444811-B2804D26-0F1C-46CB-B84C-D09F7E86E534Q40777128-0B1EC6A6-5167-42D1-ADF0-4FE670A06C14Q41157922-AC2DA9D2-3A8D-4F17-80C2-C1EEC77888EDQ42568045-480DA95B-CB3B-428F-81FD-C831B02897A6
P2860
EFNS-ENS Guidelines on the diagnosis and management of disorders associated with dementia.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年学术文章
@wuu
2012年学术文章
@zh
2012年学术文章
@zh-cn
2012年学术文章
@zh-hans
2012年学术文章
@zh-my
2012年学术文章
@zh-sg
2012年學術文章
@yue
2012年學術文章
@zh-hant
name
EFNS-ENS Guidelines on the dia ...... ders associated with dementia.
@en
EFNS-ENS Guidelines on the dia ...... ders associated with dementia.
@nl
type
label
EFNS-ENS Guidelines on the dia ...... ders associated with dementia.
@en
EFNS-ENS Guidelines on the dia ...... ders associated with dementia.
@nl
prefLabel
EFNS-ENS Guidelines on the dia ...... ders associated with dementia.
@en
EFNS-ENS Guidelines on the dia ...... ders associated with dementia.
@nl
P2093
P2860
P50
P1476
EFNS-ENS Guidelines on the diagnosis and management of disorders associated with dementia
@en
P2093
B O Popescu
E Stefanova
EFNS Scientist Panel on Dementia and Cognitive Neurology
G Gainotti
I Rektorova
P Scheltens
P2860
P304
P356
10.1111/J.1468-1331.2012.03784.X
P577
2012-09-01T00:00:00Z